Last: | $4.025 |
---|---|
Change Percent: | 0.0% |
Open: | $4.02 |
Close: | $4.025 |
High: | $4.05 |
Low: | $4.02 |
Volume: | 412,603 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.025 | $4.02 | $4.025 | $4.05 | $4.02 | 412,603 | 03-29-2024 |
$4.025 | $4.02 | $4.025 | $4.05 | $4.02 | 412,603 | 03-28-2024 |
$4.02 | $4.02 | $4.02 | $4.025 | $4.02 | 49,808 | 03-27-2024 |
$4.02 | $4.012 | $4.02 | $4.025 | $4.01 | 70,595 | 03-26-2024 |
$4.01 | $4.01 | $4.01 | $4.03 | $4.01 | 109,617 | 03-25-2024 |
$4.02 | $4.01 | $4.02 | $4.02 | $4.01 | 144,522 | 03-22-2024 |
$4.01 | $3.86 | $4.01 | $4.02 | $3.86 | 261,759 | 03-21-2024 |
$3.87 | $3.85 | $3.87 | $3.9 | $3.84 | 15,914 | 03-20-2024 |
$3.85 | $3.9 | $3.85 | $3.905 | $3.85 | 21,272 | 03-19-2024 |
$3.9 | $3.92 | $3.9 | $3.92 | $3.89 | 20,189 | 03-18-2024 |
$3.9 | $3.9 | $3.9 | $3.9 | $3.895 | 5,226 | 03-15-2024 |
$3.905 | $3.9 | $3.905 | $3.91 | $3.8998 | 18,535 | 03-14-2024 |
$3.9 | $3.9 | $3.9 | $3.91 | $3.9 | 10,447 | 03-13-2024 |
$3.9 | $3.89 | $3.9 | $3.9001 | $3.89 | 13,947 | 03-12-2024 |
$3.9 | $3.89 | $3.9 | $3.9 | $3.87 | 12,508 | 03-11-2024 |
$3.86 | $3.9 | $3.86 | $3.9 | $3.86 | 83,942 | 03-08-2024 |
$3.9 | $3.93 | $3.9 | $3.93 | $3.9 | 23,441 | 03-07-2024 |
$3.89 | $3.9 | $3.89 | $3.9147 | $3.88 | 34,905 | 03-06-2024 |
$3.9 | $3.915 | $3.9 | $3.945 | $3.89 | 154,522 | 03-05-2024 |
$3.92 | $3.92 | $3.92 | $3.92 | $3.91 | 11,705 | 03-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Genetron Holdings Limited Company Name:
GTH Stock Symbol:
NASDAQ Market:
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision onc...
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and c...
BEIJING, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision onco...